Research map: Optimizing the Meropenem Dosing Regimen in Neonates: A Dual-Centre Cohort Study

Back to the article

Papers in this map

  1. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 · Spencer Lewis James · 2018 · 14257 citations · Cited by this paper
  2. Machine learning-based drug susceptibility prediction from Candida genomic data · 2026 · Related
  3. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017 · Gregory A. Roth · 2018 · 8781 citations · Cited by this paper
  4. Emergence of dalbavancin non-susceptible methicillin-resistant Staphylococcus epidermidis (MRSE) in a patient treated with dalbavancin prolonged therapy: Case report, therapeutic drug monitoring and genomic characterization · 2026 · Related
  5. A Simple Estimate of Glomerular Filtration Rate in Children Derived From Body Length and Plasma Creatinine · George J. Schwartz · 1976 · 2391 citations · Cited by this paper
  6. Risk factors and outcome of extended-spectrum β-lactamase-producing Enterobacterales bacteraemia in high-risk neutropenic patients in haematology: A multicentre retrospective study · 2026 · Related
  7. Some suggestions for measuring predictive performance · Lewis B. Sheiner · 1981 · 1623 citations · Cited by this paper
  8. An exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae · 2026 · Related
  9. Too much of a good thing: a retrospective study of β-lactam concentration–toxicity relationships · Sahand Imani · 2017 · 324 citations · Cited by this paper
  10. Vancomycin penetration into intra-abdominal compartments: Site concentration disparities and implications for dose optimization in gram-positive infections · 2026 · Related
  11. Pharmacokinetic and Pharmacodynamic Properties of Meropenem · David P. Nicolau · 2008 · 227 citations · Cited by this paper
  12. A Novel blaTMB Allele Encoding a Functional Carbapenemase Associated with a Gamma-Mobile-Trio Island · 2026 · Related
  13. Revisiting ESKAPE Pathogens: virulence, resistance, and combating strategies focusing on quorum sensing · Parvathy Venkateswaran · 2023 · 164 citations · Cited by this paper
  14. Ecr positively regulates activity of the PhoQ/PhoP signalling system in Klebsiella pneumoniae · 2026 · Related
  15. Ethnic or Racial Differences Revisited · Mei‐Ling Chen · 2006 · 155 citations · Cited by this paper
  16. Broad-spectrum empirical antibiotic overuse in community-onset bacteraemia: Prevalence, outcomes, and associated factors · 2026 · Related
  17. Approaches to Dose Finding in Neonates, Illustrating the Variability between Neonatal Drug Development Programs · John N. van den Anker · 2020 · 98 citations · Cited by this paper
  18. Arginine metabolism and compensatory adaptations expand the impaired phage resistance repertoire in colistin-resistant Acinetobacter baumannii · 2026 · Related
  19. Population Pharmacokinetics of Meropenem in Plasma and Cerebrospinal Fluid of Infants With Suspected or Complicated Intra-abdominal Infections · P. Brian Smith · 2011 · 95 citations · Cited by this paper
  20. Vonoprazan-Based Dual and Quadruple Therapy with Varying Duration for Helicobacter pylori Eradication: A Multicenter, Randomized Controlled Trial · 2026 · Related
  21. Augmented renal clearance in pediatric intensive care: are we undertreating our sickest patients? · Evelyn Dhont · 2018 · 89 citations · Cited by this paper
  22. Meropenem Pharmacokinetics in the Newborn · John N. van den Anker · 2009 · 88 citations · Cited by this paper
  23. Safety and Effectiveness of Meropenem in Infants With Suspected or Complicated Intra-abdominal Infections · M. Cohen-Wolkowiez · 2012 · 73 citations · Cited by this paper
  24. Simulation-Based Evaluation of PK/PD Indices for Meropenem Across Patient Groups and Experimental Designs · Anders Kristoffersson · 2016 · 66 citations · Cited by this paper
  25. Meropenem vs standard of care for treatment of neonatal late onset sepsis (NeoMero1): A randomised controlled trial · Irja Lutsar · 2020 · 57 citations · Cited by this paper
  26. Short versus Long Infusion of Meropenem in Very-Low-Birth-Weight Neonates · Helgi Padari · 2012 · 53 citations · Cited by this paper
  27. Maturation of GFR in Term-Born Neonates: An Individual Participant Data Meta-Analysis · Nori J.L. Smeets · 2022 · 53 citations · Cited by this paper
  28. Developmental Pharmacokinetics in Neonates: Maturational Changes and Beyond · Karel Allegaert · 2017 · 52 citations · Cited by this paper
  29. Interethnic Differences in Pharmacokinetics of Antibacterials · Danny Tsai · 2014 · 50 citations · Cited by this paper
  30. Neonatal sepsis in a Nigerian private tertiary hospital: Bacterial isolates, risk factors, and antibiotic susceptibility patterns · EmmanuelOlushola Shobowale · 2017 · 37 citations · Cited by this paper
  31. Population Pharmacokinetics and Pharmacodynamics of Meropenem in Critically Ill Pediatric Patients · Jumpei Saito · 2020 · 37 citations · Cited by this paper
  32. Is Meropenem as a Monotherapy Truly Incompetent for Meropenem-Nonsusceptible Bacterial Strains? A Pharmacokinetic/Pharmacodynamic Modeling With Monte Carlo Simulation · Xiangqing Song · 2019 · 31 citations · Cited by this paper
  33. Population Pharmacokinetics and Model-Based Dosing Optimization of Teicoplanin in Pediatric Patients · Tao Zhang · 2020 · 25 citations · Cited by this paper
  34. Physiologically Based Pharmacokinetic Modeling in Neonates: Current Status and Future Perspectives · Wei Zhang · 2023 · 21 citations · Cited by this paper
  35. Meropenem-induced pancytopenia in a preterm neonate: a case report · Kashif Hussain · 2021 · 20 citations · Cited by this paper
  36. Desired vancomycin trough concentration to achieve an AUC0‐24/MIC ≥400 in Chinese children with complicated infectious diseases · Tao Zhang · 2019 · 17 citations · Cited by this paper
  37. Therapeutic Drug Monitoring of Antimicrobial Drugs in Neonates: An Opinion Article · Daan J. Touw · 2021 · 17 citations · Cited by this paper
  38. Optimal use of β-lactams in neonates: machine learning-based clinical decision support system · Bo‐Hao Tang · 2024 · 17 citations · Cited by this paper
  39. Target Site Pharmacokinetics of Meropenem: Measurement in Human Explanted Lung Tissue by Bronchoalveolar Lavage, Microdialysis, and Homogenized Lung Tissue · Michael Paal · 2021 · 16 citations · Cited by this paper

Source: OpenAlex (CC0)